Induced Pluripotent Stem Cells: Global Markets
商品番号：SMB-49092
| 出版社 | BCC Research |
| 出版年月 | 2024年11月 |
| ページ数 | 152 |
| 図表数 | 137 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
世界の人工多能性幹細胞（iPSC）市場は2023年に34億ドル規模になると見込まれ、2023年から2028年までの年平均成長率（CAGR）9.1％で成長し、2028年末までに52億ドルに達すると予測されています。BCC Research（BCCリサーチ）「人工多能性幹細胞（iPSC）の世界市場 – Induced Pluripotent Stem Cells: Global Markets」は世界のiPS細胞市場を調査し、主要セグメント毎に分析・予測を行っています。
主な掲載内容
- 市場力学
- 成長促進要因
- 成長阻害要因
- 市場機会
- 新技術と発展
- iPS細胞研究の発展
- 臨床治験分析
- 特許分析
- セグメント別iPS細胞市場分析
- 人工多能性幹細胞（iPSC）の生成 – リプログラミング方法別市場分析
- タイプ別iPSC由来組織細胞市場
- 種別iPSC由来組織細胞市場
- 用途別iPSC由来組織細胞市場
- 製品機能別iPSC市場
- エンドユーザ別iPSC市場
- iPSCの受託サービスタイプ
- 地域別iPSC市場
- 競争環境
- 関連企業情報
Report Highlights
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.Report Includes
- 28 data tables and 56 additional tables
- An analysis of the global market for induced pluripotent stem cells (iPSCs) or artificial stem cells
- Analyses of global market trends, with market revenue data from 2020 to 2023, and projected CAGRs through 2028
- Estimate of the size and revenue prospects of the global market, along with a market share analysis by reprogramming method, generation method, application, product function, iPSC-derived cell type, species, end use, and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, and the macroeconomic factors that influence the industry
- A Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
- Insights into iPSC research activity, emerging technologies, clinical trials and pipeline products
- Patent activity and analysis of recent patent grants/publications
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including Fujifilm Cellular Dynamics (FCDI) Inc., Axol Bioscience Ltd., Merck KGaA, Thermo Fisher Scientific Inc., and Takara Bio Inc.
Report Scope
The scope of this study encompasses an investigation of the market. BCC Research analyzes this market based on application type, product function, generation of iPSC and types of iPSC derived cells and species. Application-based market segments include drug development and toxicity testing, academic research and regenerative medicine. Product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis. iPSC-derived cell-type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells and other cell types. Other cell types include astrocytes, fibroblasts and hematopoietic progenitor cells. BCC Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts through 2028.The report also provides a detailed analysis of the market’s drivers, restraints, challenges and opportunities. In addition, the report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. it also provides detailed information on this market, emerging technologies and new developments, regulatory landscape, patent analysis, pipeline analysis and investment outlook and deals.Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||
| Base year market size | $3.1 Billion | ||||||||||||
| Market size forecast | $5.2 Billion | ||||||||||||
| Growth rate | CAGR of 9.1% from 2023 to 2028 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | By Reprogramming Method, Generation Method, Application, Product Function, iPSC-Derived Cell Type, Species, End Use, and Region | ||||||||||||
| Regions covered | The U.S., Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||||||
| Key Market Drivers |
| ||||||||||||
| Companies studied |
|
Table of Contents
Chapter 1 Executive SummaryMarket OutlookScope of ReportMarket Summary
Chapter 2 Market OverviewIntroductionInduced Pluripotent Stem Cells (iPSC) Generation
Chapter 3 Market DynamicsGlobal Market DynamicsMarket DriversIncreasing Prevalence of Chronic DiseasesIncreasing Investment in Biotechnology IndustryIncreasing Demand for Personalized MedicinesIncreasing Investments for Drug Research and DevelopmentDemand for Effective Drug Discovery and Development ProcessMinimizing Animal TestingMarket RestraintsHigh Development Costs and Lack of Skilled WorkforceChallenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug DiscoveryMarket OpportunitiesTechnological AdvancesGrowth in iPSC Banking
Chapter 4 Emerging Technologies and DevelopmentsAdvances in the iPSC ResearchReprogramming TechnologiesGene Editing Technologies3D OrganoidsRegenerative MedicineEvolution and Current Application of Artificial Intelligence (AI) in iPSC Research
Chapter 5 Clinical Trial AnalysisClinical Trials
Chapter 6 Patent AnalysisPatent Analysis
Chapter 7 Market Segmentation AnalysisSegmentation BreakdownOverviewGeneration of Induced Pluripotent Stem Cells — Market Analysis, by Reprogramming MethodMarket for Induced Pluripotent Stem Cells, by Generation MethodMarket for Induced Pluripotent Stem Cells, by ApplicationAcademic ResearchPharmaco-toxicological ScreeningDrug Discovery and DevelopmentDisease ModelingTissue EngineeringCell TherapyGlobal MarketRegional Markets for iPSCs, by ApplicationiPSC-derived Tissue Cell Market, by TypeCardiomyocytesNeuronsEndothelial CellsHepatocytesOther CellsiPSC-derived Tissue Cell Market, by SpeciesGlobal MarketiPSC-derived Tissue Cell Market, by ApplicationGlobal MarketMarket for Induced Pluripotent Stem Cells, by Product FunctionGlobal MarketRegional Markets for iPSCs, by Product FunctionMarket for Induced Pluripotent Stem Cells, by End UseInduced Pluripotent Stem Cell Contract Service TypesMajor PlayersGlobal MarketGeographic BreakdownMarket for Induced Pluripotent Stem Cells, by RegionThe U.S.EuropeAsia-PacificRest of the World
Chapter 8 Competitive IntelligenceCompetitive Landscape — OverviewStrategic AnalysisAgreementsCollaborations & Strategic AlliancesPartnershipsNew Product Development and LaunchesExpansions and AcquisitionsFund RaisingApproval and Clinical TrialsOthersMajor Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings
Chapter 9 AppendixMethodologyAbbreviationsSources
Company ProfilesATCCAXOL BIOSCIENCE LTD.BIO-TECHNEFUJIFILM CELLULAR DYNAMICS INC.LONZAMERCK KGAANCARDIAQIAGENREPROCELL INC.STEMCELL TECHNOLOGIESTAKARA BIO INC.THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028Table 1 : Projected Number of Adults 50 Years and Older with ≥1 Chronic Condition in the United States, 2020–2050Table 2 : The U.S. NIH Funding for Various Disease Conditions, 2019–2025Table 3 : Brief Information on iPSC RepositoriesTable 4 : Induced Pluripotent Stem Cells Pipeline, 2023Table 5 : List of Selected Patents Published on iPSC Technology, 2021Table 6 : List of Selected Patents Published on iPSC Technology, 2022Table 7 : List of Selected Patents Published on iPSC Technology, 2023Table 8 : List of Selected Patents Published on iPSC Technology, Till August 2024Table 9 : Summary of Different Reprogramming MethodsTable 10 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028Table 11 : Global Market for Induced Pluripotent Stem Cells, by Method, Through 2028Table 12 : Selected Interventional Clinical Trials of iPSC-based Cell TherapyTable 13 : Global Market for Induced Pluripotent Stem Cells, by Application, Through 2028Table 14 : The U.S. Market for Induced Pluripotent Stem Cells, by Application, Through 2028Table 15 : European Market for Induced Pluripotent Stem Cells, by Application, Through 2028Table 16 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Application, Through 2028Table 17 : RoW Market for Induced Pluripotent Stem Cells, by Application, Through 2028Table 18 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, Through 2028Table 19 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Species, Through 2028Table 20 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Application, Through 2028Table 21 : Global Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028Table 22 : The U.S. Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028Table 23 : European Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028Table 24 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028Table 25 : RoW Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028Table 26 : Global Market for Induced Pluripotent Stem Cells, by End Use, Through 2028Table 27 : Major Companies Providing iPSC Contract Services, by State/CountryTable 28 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2028Table 29 : Global Market for Induced Pluripotent Stem Cells, by Region, Through 2028Table 30 : The U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2028Table 31 : European Market for Induced Pluripotent Stem Cells, by Country, Through 2028Table 32 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2028Table 33 : Agreements: Induced Pluripotent Stem Cells Market, 2019-2024Table 34 : Collaborations and Strategic Alliances: Induced Pluripotent Stem Cells Market, 2019-2024Table 35 : Partnerships: Induced Pluripotent Stem Cells Market, 2020-2023Table 36 : New Product Development and Launches: Induced Pluripotent Stem Cells Market, 2020-2023Table 37 : Expansions and Acquisitions: Induced Pluripotent Stem Cells Market, 2020–2023Table 38 : Fund Raising: Induced Pluripotent Stem Cells Market, 2020-2024Table 39 : Approvals and Clinical Trials: Induced Pluripotent Stem Cells Market, 2020-2024Table 40 : Other Competitive Strategies: Induced Pluripotent Stem Cells Market, 2020-2024Table 41 : Major Companies in the Induced Pluripotent Stem Cells MarketTable 42 : Glossary of Terms Used in This ReportTable 43 : Report Information SourcesTable 44 : ATCC: Company SnapshotTable 45 : ATCC: Product PortfolioTable 46 : ATCC: News/Key Developments, 2023 and 2024Table 47 : Axol Bioscience Ltd.: Company SnapshotTable 48 : Axol Bioscience Ltd.: Product PortfolioTable 49 : Axol Bioscience Ltd.: News/Key Developments, 2021-2024Table 50 : Bio-Techne: Company SnapshotTable 51 : Bio-Techne: Financial Performance, FY 2022 and 2023Table 52 : Bio-Techne: Product PortfolioTable 53 : Bio-Techne: News/Key Developments, 2021-2023Table 54 : Fujifilm Cellular Dynamics Inc.: Company SnapshotTable 55 : Fujifilm Cellular Dynamics Inc.: Product PortfolioTable 56 : Fujifilm Cellular Dynamics Inc.: News/Key Developments, 2021–2023Table 57 : Lonza: Company SnapshotTable 58 : Lonza: Financial Performance, FY 2022 and 2023Table 59 : Lonza: Product PortfolioTable 60 : Lonza: News/Key Developments, 2020Table 61 : Merck KGaA: Company SnapshotTable 62 : Merck KGaA: Financial Performance, FY 2022 and 2023Table 63 : Merck KGaA.: Product PortfolioTable 64 : Merck KGaA: News/Key Developments, 2021-2024Table 65 : Ncardia: Company SnapshotTable 66 : Ncardia: Product PortfolioTable 67 : Ncardia: News/Key Developments, 2021-2024Table 68 : Qiagen: Company SnapshotTable 69 : Qiagen: Financial Performance, FY 2022 and 2023Table 70 : Qiagen: Product PortfolioTable 71 : REPROCELL Inc.: Company SnapshotTable 72 : REPROCELL Inc.: Product PortfolioTable 73 : REPROCELL Inc.: News/Key Developments, 2021-2024Table 74 : STEMCELL Technologies.: Company SnapshotTable 75 : STEMCELL Technologies: Product PortfolioTable 76 : STEMCELL Technologies: News/Key Developments, 2021-2022Table 77 : Takara Bio Inc.: Company SnapshotTable 78 : Takara Bio Inc.: Financial Performance, FY 2022 and 2023Table 79 : Taraka Bio Inc.: Product PortfolioTable 80 : Thermo Fisher Scientific Inc.: Company SnapshotTable 81 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023Table 82 : Thermo Fisher Scientific Inc.: Product PortfolioTable 83 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024List of Figures
Summary Figure : Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, 2020-2028Figure 1 : Methodology for the Generation of Induced Pluripotent Stem CellsFigure 2 : Snapshot of the Market Dynamics for iPSCsFigure 3 : Venture Averages for Biopharma Therapeutics and Platform Companies, 2010-2024Figure 4 : Personalized Medicines Contribution in Total FDA Approvals, 2015-2023Figure 5 : Global Pharmaceutical R&D Spending, by Select Country/Region, 2010-2022Figure 6 : Phases of the Pharmaceutical Industry Research and Development ProcessFigure 7 : iPSC-derived Organoids Used for Drug ScreeningFigure 8 : Temporal Distribution of Studies Using ESCs, iPSCs, Somatic Cell Nuclear Transfer (SCNT) Cells and Parthenotic PSCs (pPSCs), Jan 1, 2011–Dec 13, 2022Figure 9 : Clinical-trial Analysis: Induced Pluripotent Stem Cells, as of August 2024Figure 10 : Number of Patents Documented Over Time on iPSC Technology, 2010-2024Figure 11 : Number of Granted Patents Documents on iPSC Technology, by Country, 2021-2024Figure 12 : PubMed Citations and Human iPSC Lines Registered in hPSCreg and EBiSC, 2007-2022Figure 13 : Published Applications of hiPSC Technology from Top 20 Pharma Companies, 2010-2020Figure 14 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020-2028Figure 15 : Global Market Shares of Induced Pluripotent Stem Cells, by Reprogramming Method, 2022Figure 16 : Global Market for Induced Pluripotent Stem Cells, by Method, 2020-2028Figure 17 : Global Market Shares of Induced Pluripotent Stem Cells, by Method, 2022Figure 18 : Utility of hiPSCs to Humanize Drug DiscoveryFigure 19 : Autologous and Allogeneic iPSC-Based Cell TherapyFigure 20 : Global Market for Induced Pluripotent Stem Cells, by Application, 2020-2028Figure 21 : Global Market Shares of Induced Pluripotent Stem Cells, by Application, 2022Figure 22 : The U.S. Market Shares of Induced Pluripotent Stem Cells, by Application, 2022Figure 23 : European Market Shares of Induced Pluripotent Stem Cells, by Application, 2022Figure 24 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Application, 2022Figure 25 : RoW Market Shares of Induced Pluripotent Stem Cells, by Application, 2022Figure 26 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, 2020-2028Figure 27 : Global Market Shares of Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, 2022Figure 28 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Species, 2020-2028Figure 29 : Global Market Shares of Induced Pluripotent Stem Cell-derived Tissue Cells, by Application, 2022Figure 30 : Global Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022Figure 31 : The U.S. Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022Figure 32 : European Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022Figure 33 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022Figure 34 : RoW Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022Figure 35 : Global Market Shares of Induced Pluripotent Stem Cells, by End Use, 2022Figure 36 : Global Market Shares of Induced Pluripotent Stem Cell Contract Services, by Region, 2022Figure 37 : Global Market Shares of Induced Pluripotent Stem Cells, by Region, 2022Figure 38 : NIH Spending on Induced Pluripotent Stem Cell Research in the U.S., 2015-2023Figure 39 : The U.S. Market Shares of Induced Pluripotent Stem Cells, by State, 2022Figure 40 : European Market Shares of Induced Pluripotent Stem Cells, by Country, 2028Figure 41 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Country, 2022Figure 42 : Global Market Shares of Induced Pluripotent Stem Cells, by Key Strategies Adopted, 2019-2024Figure 43 : Bio-Techne: Revenue Share, by Business Unit, FY 2023Figure 44 : Bio-Techne: Revenue Share, by Country/Region, FY 2023Figure 45 : Lonza: Revenue Share, by Business Unit, FY 2023Figure 46 : Lonza: Revenue Share, by Country/Region, FY 2023Figure 47 : Merck KGaA: Revenue Share, by Business Unit, FY 2023Figure 48 : Merck KGaA: Revenue Share, by Country/Region, FY 2023Figure 49 : Qiagen: Revenue Share, by Business Unit, FY 2023Figure 50 : Qiagen: Revenue Share, by Country/Region, FY 2023Figure 51 : Takara Bio Inc.: Revenue Share, by Business Unit, FY 2023Figure 52 : Takara Bio Inc.: Revenue Share, by Country/Region, FY 2023Figure 53 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023Figure 54 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
